University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
NCT Number: NCT00403377
RATIONALE: Understanding why sunbathers use or don't use sunless tanning products may help doctors plan effective ways to prevent skin cancer caused by sunbathing.
PURPOSE: This phase I/II trial is studying attitudes about the use of sunless tanning products and how well sunless tanning products work as a substitute for sunbathing in healthy participants.
Looking for future studies?
Notify Me18 year–120 year
All sexes
Interventional
Phase 1 / Phase 2
Worcester, Massachusetts, 01655, United States
OBJECTIVES:
Primary
Secondary
OUTLINE: This is an open-label phase I study followed by a pilot, randomized, controlled phase II study.
In both arms, participants complete surveys again at 2 and 12 months.
PROJECTED ACCRUAL: A total of 330 participants will be accrued for this study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
In the intervention arm, photographs are taken of the participants and they then receive sunscreen lotion and sunless tanning lotion and instructions and benefits for using both. Participants also receive an educational pamphlet regarding skin cancer.
Time frame: Baseline and Focus Group
The goal of the initial developmental phase of the present study is to determine the acceptability of sunless tanning as a substitute for sunbathing. Using focus groups comprised of sunbathers given the opportunity to sample sunless tanning products, we will identify perceived barriers and benefits of sunless tanning products, develop motivational messages encouraging the use of sunless tanning products, and preview intervention materials.
Time frame: Baseline, 2-, and 12-months
The intervention will include sun damage imaging, sun safety and sunless tanning education/instruction, and the provision of samples of both sunscreen and sunless tanning products. Feasibility of the intervention, measures, and follow-up procedures will be assessed. The primary outcome for effectiveness will be sun exposure at 2-, and 12- months follow-up and a questionnaire only control group will be employed for comparison.
Time frame: Baseline and Focus Group
To achieve this aim, psychometric analyses including inter-item analyses, autocorrelations, internal consistency, convergent and divergent validity will be conducted, and survey items will be added/revised (if necessary) based on content of focus group discussions.
Time frame: Baseline, 2-, and 12-months
The intervention will include sun damage imaging, sun safety and sunless tanning education/instruction, and the provision of samples of both sunscreen and sunless tanning products. Feasibility of the intervention, measures, and follow-up procedures will be assessed. Secondary outcomes will include frequency of sunburns, use of sunless tanning products, sun protection behavior, and perceived benefits/barriers to sunbathing/sun protection.
University of Massachusetts, Worcester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03509467
Basal Cell Cancer, Basal Cell Carcinoma
Tampa, Florida, United States
View Trial DetailsNCT05648604
Basal Cell Carcinoma, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT02652455
Melanoma, Melanoma (Skin)
Tampa, Florida, United States
View Trial DetailsNCT04040114
Melanoma, Melanoma (Skin)
Melbourne, Victoria, Australia
View Trial Details